Medinova Diagnostic Services Ltd Financials
Company Logo

Medinova Diagnostic Services Ltd Financial Statement

Medinova Diagnostic Services Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue2.00
Operating Expense1.49
Net Profit0.25
Net Profit Margin12.50
Earning Per Share0.25
EBIDTA0.51
Effective Tax Rate17.65
Invest in Medinova Diagnostic Services Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Medinova Diagnostic Services Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual7.78
Operating Expenses Annual6.33
Operating Profit Annual1.71
Interest Annual0.57
Depreciation0.10
Net Profit Annual0.75
Tax Annual0.26

Medinova Diagnostic Services Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.61
Cash Flow from Operations1.51
Cash Flow from Investing-0.18
Cash Flow from Financing-1.32
Cash Flow at the End0.61

Medinova Diagnostic Services Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)22.49
PBIT Margin (%)20.95
PBT Margin (%)-13.24
Net PROFIT Margin (%)9.64
Return On Networth / Equity (%)6.76
Return On Networth /Employed (%)9.69
Return On Assets (%)23.62
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)2.45

Medinova Diagnostic Services Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual1.02
Total Current Assets Annual1.15
Non Current Assets Annual4.86
Total Shareholders Funds Annual-2.07
Total Assets Annual6.01

Medinova Diagnostic Services Ltd Earning Calls

EPS (INR)

Expected

0.50

Reported

0.50

Surprise

0.00%

Jun 2024

EPS beaten by 0.00%

Mar 2024

EPS beaten by 0.00%

Dec 2023

EPS beaten by 0.00%

Get Your FAQs Right

As of Nov 8, 2024, Medinova Diagnostic Services Ltd has a market capitalization of 30.61 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Medinova Diagnostic Services Ltd is debt-free with a debt-to-equity ratio of -2.42.
In FY 2023 , Medinova Diagnostic Services Ltd recorded a total revenue of approximately 7.78 Cr marking a significant milestone in the company's financial performance.
Medinova Diagnostic Services Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.0% and -0.2% annually, respectively..
Medinova Diagnostic Services Ltd's current PE ratio is 40.81.
Medinova Diagnostic Services Ltd's ROCE averaged 77.6% from the FY ending March 2022 to 2024, with a median of 54.2%. It peaked at 129.1% in March 2022, reflecting strong capital efficiency over the period..
Medinova Diagnostic Services Ltd's latest EBIT is Rs. 1.59 Cr, surpassing the average EBIT of Rs. 2 Cr over the 5 years..